Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-07-22

FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)

View source ↗

Summary

The FDA approved a supplemental application for APIDRA (insulin glulisine) submitted by Sanofi-U.S. LLC. The approval confirms the changes described in the supp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apidra (insulin glulisine)

Snippet

SUPPL AP for APIDRA (INSULIN GLULISINE)